CPT2 and pancreatic hypoplasia-diabetes-congenital heart disease syndrome: Consistent with the proteomics data, the protein levels of PPARα targets, such as FABP1, CPT2, and HMGCS2, were significantly increased, while the expression of CD36 was reduced in HDCA group (Fig. 4c).